Atazanavir General Medicines

Drug Type

General Medicines

Physical Form

Tablets

Function

Anti-Viral

Recommended For

Indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection

Dosage

Hepatic impairment For treatment naA-ve patients Mild (Child-Pugh Class A): 400 mg PO qDay Moderate (Child-Pugh Class B): 300 mg PO qDay Severe (Child-Pugh Class C): Not recommended Coadministration of atazanavir with ritonavir in patients with any degree of hepatic impairment is not recommended

Dosage Guidelines

Use of atazanavir with ritonavir in treatment-experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions

Suitable For

Suitable For All

Quantity

1000 Boxes

Certifications

FDA

FOB Port

Mumbai, Maharashtra

Packaging Details

Wooden and corrugated boxes with export level Packaging.Packaging charges Applicable or as per mutually agreed contract.

Sample Policy

Contact us for information regarding our sample policy